LENSAR, Inc. (LNSR): Total Assets
$71.43M
As of 2025-12-31
$69.56M
As of 2026-06-30
+8.6%
3-year compound annual growth
-2.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $71.43M | +7.7% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $66.30M | -4.7% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $69.58M | +24.6% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $55.84M | -16.0% | 2024-03-04, Balance as of period end |
| 2021-12-31 | $66.47M | -16.0% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $79.12M | +129.1% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $34.54M | n/a | 2021-03-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | 2025-12-31 | $71.43M | +7.7% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $104.79M | -21.5% |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | 2025-12-31 | $207.18M | +11.2% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $66.84M | +3.1% |
| Carlsmed, Inc. (CARL) | 2025-12-31 | $130.12M | +151.1% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $56.39M | -29.3% |
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $169.91M | +294.4% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $35.33M | +47.4% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $115.30M | -19.3% |
Compare LNSR, CVRX, MHUAF, APYX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗